Arkitekt Ventures is an early-stage healthcare venture capital firm founded in 2017 by neuroscientist Dr. See sector focus and contact routes.
Arkitekt Ventures is an early-stage healthcare venture capital firm founded in 2017 by neuroscientist Dr. Enke Bashllari, based in New York City, with a mission to advance human health by partnering with technical founders tackling hard science-and-technology problems. The firm’s investment thesis centers on the intersection of physical care delivery and frontier technology, targeting Seed (primary), Series A (selective follow-ons), and pre-seed stages in sectors including neurotech, AI-driven drug discovery, digital health platforms, and brain-machine interfaces, primarily in the United States with selective international exposure. Typical check sizes range from $0.5M–$1M at pre-seed, $2M–$5M at seed (typical), and $7M–$12M at Series A, with Arkitekt frequently co-investing rather than leading rounds, often alongside partners like Bessemer Venture Partners and Torch Capital. Notable portfolio companies include Sollis Health, Nanite, Mural Health, and Cofertility, the latter receiving a Series A investment from Arkitekt in April 2025. A distinctive point of view is Arkitekt’s high concentration in brain and nervous-system innovation, framing a “n
Every field above is read from the StartupFundraising firm directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with comparable investors when building a target list.
Investors like Arkitekt Ventures · Full investor directory · Investor access · Company funding database